Irbesartan Tablet
Product Images NDC 70518-1690

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Irbesartan (NDC 70518-1690). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Label for Irbesartan 150 mg oral tablets by RemedyRepack Inc., indicating a quantity of 90 tablets. The label includes dosing form, manufacturer details, NDC 70518-1690-01, storage instructions, and a warning to keep medication out of children's reach.*
FDA Label Image

Structure (Spl Image1 Structure)

Structure (Spl Image1 Structure)
Chemical structure of Irbesartan, showing its molecular arrangement with characteristic bicyclic and aromatic rings and functional groups.*
FDA Label Image

Figure 1 (Spl Image2 Figure1)

Figure 1 (Spl Image2 Figure1)
A scatter plot with a fitted curve showing the relationship between Irbesartan dose in mg/day on the x-axis and placebo-subtracted reduction in trough SeSBP (mmHg) on the y-axis, illustrating the integrated analysis of dose response.*
FDA Label Image

Figure 2 (Spl Image3 Figure2)

Figure 2 (Spl Image3 Figure2)
A graph showing placebo-subtracted reduction in trough SeDBP (systolic blood pressure) plotted against Irbesartan dose in mg per day. The plot includes scattered data points and a fitted curve indicating the relationship between dose and blood pressure reduction up to 900 mg/day.*
FDA Label Image

Figure 3 (Spl Image4 Figure3)

Figure 3 (Spl Image4 Figure3)
A line graph showing cumulative event rate (%) over months of follow-up (0 to 60) for Irbesartan, Amlodipine, and Placebo. Three lines represent each group with data indicating event progression over time. A legend includes relative risk (RR) and p-values comparing Irbesartan to Placebo and Amlodipine.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.